[1] |
Iizuka H, Harada S, Iwao N, et al. Primary skeletal muscle peripheral T-cell lymphoma: an autopsy case report and review of the literature[J]. Intern Med, 2021, 60(20):3309-3315.
|
[2] |
Fragou M, Karakitsos D, Kalogeromitros A, et al. Peripheral T-cell lymphoma presenting as an ischemic stroke in a 23-year-old woman: a case report and review of the literature[J]. J Med Case Rep, 2009, 3:83.
|
[3] |
Alekshun TJ, Rezania D, Ayala E, et al. Skeletal muscle peripheral T-cell lymphoma[J]. J Clin Oncol, 2008, 26(3):501-503.
doi: 10.1200/JCO.2007.14.2794
pmid: 18202425
|
[4] |
Chim CS, Loong F, Ooi GC, et al. Primary skeletal muscle lymphoma[J]. Am J Med, 2002, 112(1):79-80.
pmid: 11812416
|
[5] |
Liu Z, Medeiros LJ, Young KH. Peripheral T-cell lymphoma with unusual clinical presentation of rhabdomyolysis[J]. Hematol Oncol, 2017, 35(1):125-129.
doi: 10.1002/hon.2203
pmid: 25921311
|
[6] |
Tanaka Y, Hayashi Y, Kato J, et al. Diffuse skeletal muscles uptake of [18F] fluorodeoxyglucose on positron emission tomography in primary muscle peripheral T-cell lymphoma[J]. Intern Med, 2011, 50(18):2021-2024.
|
[7] |
Sasaki K, Yamato M, Yasuda K, et al. Rhabdomyolysis caused by peripheral T-cell lymphoma in skeletal muscle[J]. Am J Emerg Med, 2013, 31(10):1537.
|
[8] |
Yamaguchi H, Hashimoto M, Mizuki T, et al. Skeletal muscle T-cell lymphoma following hemophagocytic syndrome[J]. Rinsho Ketsueki, 2000, 41(9):712-717.
pmid: 11070931
|
[9] |
Yang J, Zhang F, Fang H, et al. Clinicopathologic features of primary lymphoma in soft tissue[J]. Leuk Lymphoma, 2010, 51(11):2039-2046.
|
[10] |
李小秋, 李甘地, 高子芬, 等. 中国淋巴瘤亚型分布:国内多中心性病例10 002例分析[J]. 诊断学理论与实践, 2012, 11(2):111-115.
|
[11] |
Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study[J]. Blood, 2004, 103(7):2474-2479.
doi: 10.1182/blood-2003-09-3080
pmid: 14645001
|
[12] |
Feeney J, Horwitz S, Gönen M, et al. Characterization of T-cell lymphomas by FDG PET/CT[J]. AJR Am J Roentgenol, 2010, 195(2):333-340.
|
[13] |
Savage KJ, Ferreri AJ, Zinzani PL, et al. Peripheral T-cell lymphoma—not otherwise specified[J]. Crit Rev Oncol Hematol, 2011, 79(3):321-329.
doi: 10.1016/j.critrevonc.2010.07.007
pmid: 20702104
|
[14] |
Huang HS, Liao CK, Liu TT, et al. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression[J]. Hum Pathol, 2018, 80:145-151.
|
[15] |
Abouyabis AN, Shenoy PJ, Sinha R, et al. A Systematic review and meta-analysis of front-line anthracycline-based chemotherapy regimens for peripheral T-cell lymphoma[J]. ISRN Hematol, 2011, 2011:623924.
|
[16] |
Derenzini E, Casadei B, Pellegrini C, et al. Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series[J]. Clin Lymphoma Myeloma Leuk, 2013, 13(3):258-265.
doi: 10.1016/j.clml.2012.10.003
pmid: 23246162
|